A Phase 2 Randomized Controlled Trial of Selonsertib in Moderate and Severe Diabetic Kidney Disease – Oral abstracts
Document Type
Presentation
Publication Date
11-1-2022
Keywords
washington; spokane; prmc
Clinical Institute
Kidney & Diabetes
Department
Endocrinology
Department
Nephrology
Recommended Citation
Tuttle, Katherine, "A Phase 2 Randomized Controlled Trial of Selonsertib in Moderate and Severe Diabetic Kidney Disease – Oral abstracts" (2022). Articles, Abstracts, and Reports. 6848.
https://digitalcommons.providence.org/publications/6848
Comments
Presented at the ASN Kidney Week 2022 Orlando, FL